60 results on '"Bult, Auke"'
Search Results
2. Teniposide
3. Mitoxantrone Hydrochloride
4. Mitomycin C
5. Silver Sulfadiazine
6. Sodium Nitroprusside
7. Stability and compatibility of the investigational antimetastatic ruthenium complex NAMI-A in infusion systems and its hemolytic potential
8. On-line coupling of size exclusion and capillary zone electrophoresis via a reversed-phase C18 trapping column for the analysis of structurally related enkephalins in cerebrospinal fluid
9. On‐line coupling of size‐exclusion chromatography and capillary zone electrophoresis via a reversed‐phase C18 trapping column for the determination of peptides in biological samples
10. Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A
11. On-line coupling of SEC and RP–LC for the determination of structurally related enkephalins in cerebrospinal fluid
12. Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A
13. A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A
14. Compatibility and Stability of the Investigational Polypeptide Marine Anticancer Agent Kahalalide F in Infusion Devices
15. Development of an on-line size exclusion chromatographic — reversed-phase liquid chromatographic two-dimensional system for the quantitative determination of peptides with concentration prior to reversed-phase liquid chromatographic separation
16. Robust and cost-effective capillary electrophoresis-mass spectrometry interfaces suitable for combination with on-line analyte preconcentration
17. Capillary electrophoretic bioanalysis of therapeutically active peptides with UV and mass spectrometric detection after on-capillary preconcentration
18. On-line sample preconcentration in capillary electrophoresis, focused on the determination of proteins and peptides
19. Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution
20. Derivatization trends in capillary electrophoresis
21. Quantitative analysis of pharmaceutically active peptides using on-capillary analyte preconcentration transient isotachophoresis
22. Quantitative analysis of pharmaceutically active peptides using on-capillary analyte preconcentration transient isotachophoresis
23. Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction
24. Degradation of Azaglycinamido Residues in Model Tripeptides Derived from Goserelin
25. Protein kinase C as a target for new anti-cancer agents
26. Comparison between transient isotachophoretic capillary zone electrophoresis and reversed-phase liquid chromatography for the determination of peptides in plasma
27. Reduction of Cys36–Cys42 and Cys64–Cys74 disulfide bonds in recombinant human granulocyte colony stimulating factor
28. Interaction between Plasmid DNA and Cationic Polymers Studied by Surface Plasmon Resonance Spectrometry
29. Development and validation of transient isotachophoretic capillary zone electrophoresis for determination of peptides
30. Analytical techniques used to study the degradation of proteins and peptides: physical instability
31. Analytical techniques used to study the degradation of proteins and peptides: chemical instability
32. O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan
33. Oxidation of recombinant methionyl human granulocyte colony stimulating factor
34. Identification of the Degradation Products of Gonadorelin and Three Analogues in Aqueous Solution
35. Decrease of the stage-2 deposition in the twin impinger during storage of beclomethasone dipropionate dry powder inhalers in controlled and uncontrolled humidities
36. Capillary zone electrophoresis–mass spectrometry as a tool in the stability research of the luteinising hormone-releasing hormone analogue goserelin
37. Pre-, on- and post-column derivatization in capillary electrophoresis
38. Degradation Kinetics of Gonadorelin in Aqueous Solution
39. Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9
40. Precolumn fluorescence derivatization of the antagonist [Arg6,d-Trp7,9, MePhe8]-Substance P 6–11 with benzoin in high-performance liquid chromatography and selective detection of arginine-containing fragments in its degradation products
41. Structural Identification of the Degradation Products of the Antitumor Peptide Antagonist [Arg6,D-Trp7,9,MePhe8]Substance P (6-11)
42. Substitution of Didanosine Sachets by Chewable Tablets
43. Selective determination of peptides containing specific amino acid residues by high-performance liquid chromatography and capillary electrophoresis
44. Limited sampling models for the antiretroviral agent didanosine
45. Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)
46. Therapeutic Drug Monitoring of Phenytoin in Patients with the Acquired Immunodeficiency Syndrome
47. Pharmacokinetic variability of zidovudine in HIV-infected individuals
48. Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9
49. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography
50. Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.